tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

USANA Health Sciences Inc

USNA
Add to Watchlist
22.110USD
-0.030-0.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
408.22MMarket Cap
44.63P/E TTM

USANA Health Sciences Inc

22.110
-0.030-0.14%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

USNA Financials

See USANA Health Sciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

USANA Health Sciences Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/0.43
Revenue / Forecast
--/235.00M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
925.26M
8.28%
EPS(YoY)
0.58
-73.61%
Analyst Rating
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-17.24%0.41
-141.60%-0.10
-164.13%-0.36
-4.65%0.52
-42.77%0.49
-73.35%0.23
-5.70%0.56
-38.89%0.55
-9.53%0.86
31.56%0.88
--0.59
--0.89
--0.95
--0.67
--2.94
----
----
----
----
----
Revenue
0.27%250.22M
5.89%226.20M
6.72%213.67M
10.79%235.85M
9.54%249.54M
-3.38%213.61M
-6.16%200.22M
-10.64%212.87M
-8.28%227.80M
-3.02%221.08M
-8.54%213.37M
-9.93%238.20M
-8.98%248.36M
-14.72%227.96M
-14.96%233.30M
-21.48%264.47M
-11.40%272.87M
-13.92%267.30M
-8.09%274.35M
30.06%336.84M
Net Profit
-20.07%7.51M
-139.85%-1.77M
-161.49%-6.52M
-7.45%9.65M
-43.15%9.40M
-73.43%4.45M
-6.52%10.61M
-39.67%10.43M
-10.04%16.54M
31.04%16.77M
-23.99%11.35M
-9.74%17.29M
-18.19%18.38M
-37.03%12.79M
-45.38%14.93M
-49.90%19.16M
-26.62%22.47M
-48.72%20.32M
-10.41%27.33M
36.66%38.23M
Net Margin
-25.29%2.78%
-133.59%-0.71%
-158.85%-3.12%
-9.64%4.43%
-48.72%3.72%
-72.32%2.10%
-0.38%5.30%
-32.49%4.90%
-1.92%7.26%
35.11%7.58%
--5.32%
--7.26%
--7.40%
--5.61%
--7.34%
----
----
----
----
----
Gross Margin
-3.47%76.25%
-4.63%78.16%
-4.03%77.15%
-2.88%78.72%
-2.60%78.98%
1.35%81.95%
0.41%80.39%
-0.93%81.05%
0.78%81.09%
1.54%80.86%
--80.07%
--81.81%
--80.46%
--79.63%
--80.87%
----
----
----
----
----
Debt to assets ratio
-38.50%1.89%
-38.70%1.88%
--0.00%
--0.00%
1368.58%3.08%
2374.70%3.07%
--0.00%
--0.00%
--0.21%
--0.12%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Income Statement
Revenue
0.27%250.22M
5.89%226.20M
6.72%213.67M
10.79%235.85M
9.54%249.54M
-3.38%213.61M
-6.16%200.22M
-10.64%212.87M
-8.28%227.80M
-3.02%221.08M
-8.54%213.37M
-9.93%238.20M
-8.98%248.36M
-14.72%227.96M
-14.96%233.30M
-21.48%264.47M
-11.40%272.87M
-13.92%267.30M
-8.09%274.35M
30.06%336.84M
Operating profit
-11.47%13.87M
110.10%17.25M
-92.15%1.22M
-6.29%16.72M
-36.49%15.67M
-66.10%8.21M
-11.39%15.60M
-26.89%17.84M
-8.09%24.67M
7.40%24.22M
-22.20%17.61M
-16.91%24.40M
-18.82%26.84M
-28.42%22.55M
-44.49%22.63M
-45.34%29.37M
-25.18%33.07M
-40.03%31.50M
-10.11%40.77M
35.70%53.72M
Net Profit
-20.07%7.51M
-139.85%-1.77M
-161.49%-6.52M
-7.45%9.65M
-43.15%9.40M
-73.43%4.45M
-6.52%10.61M
-39.67%10.43M
-10.04%16.54M
31.04%16.77M
-23.99%11.35M
-9.74%17.29M
-18.19%18.38M
-37.03%12.79M
-45.38%14.93M
-49.90%19.16M
-26.62%22.47M
-48.72%20.32M
-10.41%27.33M
36.66%38.23M
Balance Sheet
Current assets
4.56%294.23M
3.30%288.40M
-41.47%264.06M
-37.51%261.87M
-33.17%281.39M
-33.17%279.19M
15.55%451.19M
8.11%419.08M
6.36%421.07M
8.68%417.75M
14.45%390.46M
13.35%387.65M
8.82%395.88M
5.28%384.38M
-7.40%341.15M
-10.35%342.00M
-2.52%363.79M
-14.15%365.12M
-4.56%368.43M
17.40%381.51M
Total current liabilities
-14.66%117.24M
-7.92%128.56M
3.38%118.66M
17.06%121.63M
21.98%137.38M
17.48%139.63M
1.97%114.78M
-8.73%103.90M
-13.51%112.63M
-17.37%118.84M
-10.56%112.56M
-14.79%113.84M
-17.56%130.22M
-10.55%143.83M
-20.33%125.85M
-12.68%133.59M
4.30%157.97M
-4.33%160.79M
-1.80%157.96M
9.51%153.00M
Total assets
-1.02%738.97M
-0.71%742.91M
8.24%726.59M
16.33%734.53M
18.64%746.60M
18.24%748.19M
11.67%671.31M
4.77%631.42M
3.92%629.27M
6.07%632.76M
8.11%601.15M
8.02%602.68M
5.69%605.53M
3.26%596.55M
-3.95%556.06M
-5.66%557.96M
-1.98%572.92M
-9.85%577.74M
0.24%578.95M
15.48%591.45M
Total liabilities
-11.40%144.18M
-3.22%156.64M
4.93%145.04M
24.96%148.97M
25.86%162.72M
19.41%161.86M
5.71%138.22M
-10.94%119.21M
-13.91%129.29M
-16.36%135.56M
-9.80%130.75M
-13.24%133.86M
-17.92%150.18M
-11.25%162.08M
-19.40%144.96M
-10.73%154.28M
0.68%182.97M
-8.34%182.62M
-4.54%179.87M
5.98%172.83M
Total equity
1.87%594.79M
-0.01%586.27M
9.09%581.55M
14.32%585.56M
16.78%583.87M
17.93%586.33M
13.33%533.09M
9.25%512.21M
9.80%499.99M
14.44%497.20M
14.42%470.39M
16.14%468.82M
16.77%455.35M
9.96%434.47M
3.01%411.10M
-3.57%403.68M
-3.19%389.95M
-10.53%395.12M
2.56%399.08M
19.92%418.62M
Cash Flow Statement
Net operating income
-36.97%9.76M
-158.60%-3.39M
-106.64%-1.96M
52.92%12.22M
-12.45%15.48M
-77.77%5.79M
32.83%29.53M
-16.34%7.99M
37.79%17.68M
-35.69%26.02M
-23.66%22.23M
-34.64%9.55M
-34.86%12.83M
62.36%40.46M
-22.31%29.13M
-62.68%14.61M
0.21%19.70M
-47.99%24.92M
-23.59%37.49M
19.98%39.16M
Net investment
32.98%-2.60M
100.54%1.11M
-36.78%-3.20M
-169.21%-4.16M
4.74%-3.88M
-2701.67%-205.14M
-60.80%-2.34M
-963.69%-1.55M
-20.43%-4.07M
-123.10%-7.32M
59.37%-1.45M
104.81%179.00K
-89.14%-3.38M
-4.09%-3.28M
44.53%-3.58M
-149.20%-3.72M
42.16%-1.79M
85.29%-3.15M
-136.16%-6.45M
2.10%-1.49M
Net financing
74.83%-3.64M
-41.33%13.45M
-1155.13%-979.00K
-2753.66%-38.61M
-21.10%-14.47M
3384.80%22.93M
99.33%-78.00K
-2360.00%-1.35M
-273.43%-11.95M
538.67%658.00K
-26356.82%-11.64M
99.47%-55.00K
83.67%-3.20M
99.54%-150.00K
99.91%-44.00K
67.46%-10.30M
72.20%-19.59M
-6773.94%-32.45M
-108809.30%-46.83M
-42114.67%-31.66M

FAQs

What is the total revenue of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total revenue reached 925.26M, with a year-on-year change of 854.50M.

What are the current assets of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its current assets were 288.40M, with a year-on-year change of 3.30.

What are the total assets of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total assets of USANA Health Sciences Inc were 742.91M, with a year-on-year change of -0.71.

What are the total liabilities of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total liabilities of USANA Health Sciences Inc were 156.64M, with a year-on-year change of -3.22.

What is the total equity of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total equity of USANA Health Sciences Inc was 586.27M, with a year-on-year change of -0.01.

What is the net operating income of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net operating income of USANA Health Sciences Inc was 50.86M, with a year-on-year change of -23.31.

What is the net investment of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net investment of USANA Health Sciences Inc was -10.12M, with a year-on-year change of 95.25.

What is the net financing of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net financing of USANA Health Sciences Inc was -40.60M, with a year-on-year change of -525.03.

What is the Earnings Per Share (EPS) of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.58, with a year-on-year change of -73.61.

What is the net income of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net income was 10.76M, with a year-on-year change of -74.40.

What is the net margin of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net profit margin was 1.24, with a year-on-year change of -74.80.

What is the gross margin of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its gross margin was 78.29, with a year-on-year change of -3.50.

What is the debt-to-asset ratio of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its debt-to-asset ratio was 1.88, with a year-on-year change of -38.70.

What is the Return on Equity (ROE) of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its Return on Equity (ROE) was 2.02, with a year-on-year change of -75.26.

What is the Return on Assets (ROA) of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its Return on Assets (ROA) was 1.54, with a year-on-year change of -74.73.

What is the operating profit of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its operating profit was 50.86M, with a year-on-year change of -23.31.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy